Valuation: Captor Therapeutics Spolka Akcyjna

Market Cap 464M 124M 108M 100M 92.2M 174M 11.8B 177M 1.18B 5.88B 465M 455M 19.41B P/E 2026 *
23.8x
P/E 2027 * -281x
Enterprise Value 391M 104M 90.76M 84.73M 77.79M 147M 9.95B 149M 999M 4.96B 392M 384M 16.37B EV / Sales 2026 *
6.9x
EV / Sales 2027 * 8.13x
Free-Float
70.69%
Yield 2026 *
-
Yield 2027 * -
1 day-1.37%
1 week-3.49%
Current month-2.96%
1 month-4.89%
3 months-9.89%
6 months-8.86%
1 week 71.7
Extreme 71.7
75
1 month 70.8
Extreme 70.8
76
Current year 70.2
Extreme 70.2
89.2
1 year 33
Extreme 33
89.2
3 years 31.2
Extreme 31.2
135.5
5 years 31.2
Extreme 31.2
209
10 years 31.2
Extreme 31.2
209
Manager TitleAgeSince
Chief Executive Officer 41 31/05/2025
Director of Finance/CFO - 01/02/2025
Chief Tech/Sci/R&D Officer - 01/03/2024
Director TitleAgeSince
Chairman 54 30/06/2022
Director/Board Member 74 30/06/2022
Director/Board Member - 30/06/2022
Date Insider Type Main position Quantity % Market Cap.
2/26/26 A Buy 1,100 0.0198%
12/12/25 A Free

Chairman

360,074 6.5128%
12/12/25 A Don

Chairman

360,074 6.5128%
Change 5-day change 1-year change 3-year change Capi.($)
-1.37%-3.49%+76.47%-47.06% 124M
-0.34%-0.14%-1.10%+13.47% 48.22B
+3.20%+1.54%+402.15%+498.21% 38.79B
-2.10%-5.99%+24.98%+5.29% 38.41B
+0.89%-4.65%+3.55%+55.78% 34.88B
+1.98%+3.97%+13.89%+40.90% 29.19B
-0.29%+0.09%+32.15%+120.85% 16B
-0.56%-5.00% - - 16.05B
+1.65%+0.50%+3.49%+16.87% 13.53B
-1.62%-13.60%-5.51%-38.54% 12.22B
Average +0.08%-0.80%+61.12%+73.97% 24.74B
Weighted average by Cap. +0.33%+0.21%+75.80%+108.06%

Financials

2026 *2027 *
Net sales 56.7M 15.13M 13.15M 12.28M 11.27M 21.25M 1.44B 21.62M 145M 719M 56.84M 55.58M 2.37B 48.5M 12.94M 11.25M 10.5M 9.64M 18.18M 1.23B 18.5M 124M 615M 48.62M 47.54M 2.03B
Net income -3M -801K -696K -650K -596K -1.12M -76.31M -1.14M -7.66M -38.06M -3.01M -2.94M -126M -1.5M -400K -348K -325K -298K -562K -38.16M -572K -3.83M -19.03M -1.5M -1.47M -62.76M
Net Debt -72.5M -19.35M -16.82M -15.7M -14.41M -27.18M -1.84B -27.65M -185M -920M -72.68M -71.07M -3.03B -69.5M -18.55M -16.12M -15.05M -13.82M -26.05M -1.77B -26.5M -177M -882M -69.67M -68.13M -2.91B
Logo Captor Therapeutics Spolka Akcyjna
Captor Therapeutics SA is a Poland-based biopharmaceutical company, which specializes in the development of drugs that cause the targeted degradation of pathogenic proteins. The Company works in the field of neoplastic and autoimmune diseases for which there is no treatment option, or the available methods show therapeutic limitations. The Company covers aspects of early-stage drug development to deliver therapeutics for life-threatening and life-impairing diseases. The broadly applicable Optigrade tm Targeted Protein Degradation (TPD) platform allows for the creation of new drugs.
Employees
-
Date Price Change Volume
04/08/26 PLN 72.00 -1.37% 2,056
03/08/26 PLN 73.00 -1.62% 6,168
31/07/26 PLN 74.20 0.00% 2,718
30/07/26 PLN 74.20 -0.54% 2,282
29/07/26 PLN 74.60 0.00% 1,619
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
73.00PLN
Average target price
86.83PLN
Spread / Average Target
+18.95%

Quarterly revenue - Rate of surprise